Product
HRS-2189
1 clinical trial
1 indication
Indication
Advanced Malignant TumorClinical trial
A Single Arm, Open, Multicenter Phase I Clinical Study on the Safety, Tolerance, and Pharmacokinetics of HRS-2189 Single Drug in Patients With Advanced Malignant Solid TumorsStatus: Recruiting, Estimated PCD: 2025-12-31